Article Details
Retrieved on: 2024-09-15 10:17:30
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses trials on innovative treatments for wet AMD, focusing on reducing treatment burdens. Both intravitreal gene therapy and tyrosine kinase inhibition are explored, including methods like intravitreal administration and anti-VEGF treatment. Sheryl Stevenson's interview provides updates on these trials.
Article found on: www.ophthalmologytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here